Paper Chase is a research database designed to offer abstracts of research articles published in journals that have a highly rated impact factor as determined by ISI Impact Factor and PageRank. Abstracts are organized by date, with the most recently published papers listed first. 

Paper Chase

181.

Comprehensive clinical care for men who have sex with men: an integrated approach.

Lancet.
Mayer KH, Bekker LG, Stall R, Grulich AE, Colfax G, Lama JR.
| Jul 28, 2012
182.

Effect of physical inactivity on major non-communicable diseases worldwide: an analysis of burden of disease and life expectancy.

Lancet.
Lee IM, Shiroma EJ, Lobelo F, Puska P, Blair SN, Katzmarzyk PT, Alkandari JR.
| Jul 21, 2012
183.

Cholera.

Lancet.
Harris JB, LaRocque RC, Qadri F, Ryan ET, Calderwood SB.
| Jun 30, 2012
184.

Co-formulated elvitegravir, cobicistat, emtricitabine, and tenofovir versus co-formulated efavirenz, emtricitabine, and tenofovir for initial treatment of HIV-1 infection: a randomised, double-blind, phase 3 trial, analysis of results after 48 weeks.

Lancet.
Sax PE, DeJesus E, Mills A, Zolopa A, Cohen C, Wohl D, Gallant JE, Liu HC, Zhong L, Yale K, White K, Kearney BP, Szwarcberg J, Quirk E, Cheng AK, Akil B.
| Jun 30, 2012
185.

Pulmonary embolism and deep vein thrombosis.

Lancet.
Goldhaber SZ, Bounameaux H.
| May 12, 2012
186.

Are we ready to recommend aspirin for cancer prevention?

Lancet.
Chan AT, Cook NR.
| Apr 28, 2012
187.

Towards regenerative therapy for cardiac disease.

Lancet.
Ptaszek LM, Mansour M, Ruskin JN, Chien KR.
| Mar 10, 2012
188.

Improving medication safety.

Lancet.
Schnipper JL, Rothschild JM.
| Apr 7, 2012
189.

Survival of children with burn injuries.

Lancet.
Tompkins RG.
| Mar 17, 2012
190.

Lapatinib with trastuzumab for HER2-positive early breast cancer (NeoALTTO): a randomised, open-label, multicentre, phase 3 trial.

Lancet.
Baselga J, Bradbury I, Eidtmann H, Di Cosimo S, de Azambuja E, Aura C, Gómez H, Dinh P, Fauria K, Van Dooren V, Aktan G, Goldhirsch A, Chang TW, Horváth Z, Coccia-Portugal M, Domont J, Tseng LM, Kunz G, Sohn JH, Semiglazov V, Lerzo G, Palacova M, Probachai V, Pusztai L, Untch M, Gelber RD, Piccart-Gebhart M, Lerzo G.
| Feb 18, 2012
191.

β-agonists for ARDS: the dark side of adrenergic stimulation?

Lancet.
Thompson BT.
| Jan 21, 2012
192.

Bioartificial tissues and organs: are we ready to translate?

Lancet.
Ott HC, Mathisen DJ.
| Dec 10, 2011
193.

Statins and safety: can we finally be reassured?

Lancet.
Kohli P, Cannon CP.
| Dec 10, 2011
194.

Denosumab and bone-metastasis-free survival in men with castration-resistant prostate cancer: results of a phase 3, randomised, placebo-controlled trial.

Lancet.
Smith MR, Saad F, Coleman R, Shore N, Fizazi K, Tombal B, Miller K, Sieber P, Karsh L, Damião R, Tammela TL, Egerdie B, Van Poppel H, Chin J, Morote J, Gómez-Veiga F, Borkowski T, Ye Z, Kupic A, Dansey R, Goessl C.
| Jan 7, 2012
195.

Medical complications associated with earthquakes.

Lancet.
Bartels SA, VanRooyen MJ.
| Feb 25, 2012
196.

Aspirin and colorectal cancer prevention in Lynch syndrome.

Lancet.
Chan AT, Lippman SM.
| Dec 17, 2011
197.

Time for zero deaths from tuberculosis.

Lancet.
Keshavjee S, Harrington M, Gonsalves G, Chesire L, Farmer PE.
| Oct 22, 2011
198.

A global scope for global health--including mental health.

Lancet.
Raviola G, Becker AE, Farmer P.
| Nov 5, 2011
199.

Accurate hypertension diagnosis is key in efficient control.

Lancet.
Gaziano TA.
| Oct 1, 2011
200.

Folate and cardiovascular disease: one size does not fit all.

Lancet.
Rimm EB, Stampfer MJ.
| Aug 13, 2011